Newswire (Published: Tuesday, August 1, 2017, Received: Thursday, July 27, 2017, 6:29:31 PM CDT)

Word Count: 347

By a News Reporter-Staff News Editor at Cancer Weekly -- A new study on Oncology - Prostate Cancer is now available. According to news reporting originating in New York City, New York, by NewsRx journalists, research stated, "Advancements in magnetic resonance imaging (MRI) and MRI-ultrasound (US)-fusion targeted biopsy have resulted in a paradigm shift in the diagnosis of prostate cancer by overcoming the limitations of systematic biopsy. Prebiopsy MRI and MRI-US-fusion biopsy results in an increased detection of clinically significant disease, reduction in the detection of indolent disease, and allows for tumor localization during targeted biopsy."

The news reporters obtained a quote from the research from the Department of Surgery, "With these advantages, we have adopted a prebiopsy MRI and MRI-US-fusion biopsy diagnostic care pathway for all men at risk for prostate cancer and have performed more than 1900 biopsies to date. Herein we present our institutional development of MRI-US-fusion biopsy and highlight our results in those men who have had a previous negative biopsy, no prior biopsy, and those with a prior cancer diagnosis who may be candidate for active surveillance."

According to the news reporters, the research concluded: "Risk stratification with biomarkers and nomograms may allow for further counseling on the need for biopsy and the risk of harboring clinically significant disease."

For more information on this research see: MRI-fusion biopsy: the contemporary experience. Translational Andrology and Urology, 2017;6(3):483-489 (see also Oncology - Prostate Cancer).

Our news correspondents report that additional information may be obtained by contacting M.A. Bjurlin, Division of Urology, Dept. of Surgery, New York University Lutheran Medical Center, New York University Langone Health System, New York, NY, United States. Additional authors for this research include A.B. Rosenkrantz and S.S Taneja.

Keywords for this news article include: Oncology, Ultrasound, Epidemiology, New York City, United States, Article Review, Risk and Prevention, North and Central America, Magnetic Resonance Imaging, Metastatic Prostate Cancer.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC


      Healthcare Facilities
            Cancer Centers


Central America
North America
United States
New York
New York City


Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
            Urological Diseases
      Health Sciences
            Medical Research
      Medical Specialties and Practices
      Treatments and Therapies